Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
224,632,187
-
Shares change
-
+18,856,275
-
Total reported value, excl. options
-
$3,376,722,825
-
Value change
-
+$286,532,653
-
Put/Call ratio
-
63%
-
Number of buys
-
120
-
Number of sells
-
72
-
Price
-
$15.04
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2018
As of 31 Mar 2018 AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) had 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 224,632,187 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Redmile Group, LLC, JENNISON ASSOCIATES LLC, venBio Select Advisor LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 254 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.